The marker "CD16+ or CD56+/ CD3+" refers to a subset of immune cells that express CD16 or CD56 surface proteins along with CD3. These markers are typically associated with a specific type of T cell known as NKT (Natural Killer T) cells. NKT cells are unique because they share properties of both NK cells and conventional T cells, playing a versatile role in the immune system. CD16 and CD56: These are markers commonly found on NK cells, which are part of the innate immune system. CD16 is a receptor that allows these cells to recognize and destroy antibody-coated target cells, while CD56 is an adhesion molecule that facilitates cell-cell interactions and migration. CD3: This is a marker that is characteristic of T cells, specifically associated with the T-cell receptor (TCR) complex. The presence of CD3 indicates that these cells have T-cell lineage, allowing them to participate in adaptive immune responses. When immune cells are "CD16+ or CD56+ CD3+", it implies they are a specialized subset that can respond quickly to infected or transformed cells, combining the rapid, non-specific response typical of NK cells with the specific, adaptive responses characteristic of T cells. These cells play roles in immune regulation, autoimmune disease responses, cancer surveillance, and infection defense. Understanding the presence and levels of CD16+ or CD56+ CD3+ cells can provide insights into the state of the immune system, especially in contexts such as autoimmune diseases, cancer immunology, and infectious diseases.
Lymphocyte monitoring (NKT-like and double-negative T cells)
This category groups two lymphocyte subsets measured by flow cytometry. Each one is reported as a percentage and an absolute count. They are usually measured as part of a wider lymphocyte panel rather than on their own.
What the panel measures:
- CD16+ or CD56+ / CD3+ cells: T cells that also carry markers usually found on natural killer cells. They are often called NKT-like cells and share features of both cell types.
- CD3+ CD4− CD8− cells (double-negative T cells): T cells that carry neither the CD4 nor the CD8 marker. Many of them are gamma-delta T cells.
How to read the results:
- Both subsets are small in healthy adults, and published ranges vary between labs. Use the range on your own report.
- Mild increases in double-negative T cells are common and usually non-specific. Assessing autoimmune lymphoproliferative syndrome (ALPS), a rare condition, needs a specific alpha-beta subset of these cells, which this broader count cannot show.
- Shifts in NKT-like cells have been reported with infection, inflammation and aging, but they do not point to a single cause.
Biomarkers in this category
4 biomarkers · optimal ranges shown
The marker "CD16+ or CD56+/ CD3+" refers to a subset of immune cells that express CD16 or CD56 surface proteins along with CD3. These markers are typically associated with a specific type of T cell known as NKT (Natural Killer T) cells. NKT cells are unique because they share properties of both NK cells and conventional T cells, playing a versatile role in the immune system. CD16 and CD56: These are markers commonly found on NK cells, which are part of the innate immune system. CD16 is a receptor that allows these cells to recognize and destroy antibody-coated target cells, while CD56 is an adhesion molecule that facilitates cell-cell interactions and migration. CD3: This is a marker that is characteristic of T cells, specifically associated with the T-cell receptor (TCR) complex. The presence of CD3 indicates that these cells have T-cell lineage, allowing them to participate in adaptive immune responses. When immune cells are "CD16+ or CD56+ CD3+", it implies they are a specialized subset that can respond quickly to infected or transformed cells, combining the rapid, non-specific response typical of NK cells with the specific, adaptive responses characteristic of T cells. These cells play roles in immune regulation, autoimmune disease responses, cancer surveillance, and infection defense. Understanding the presence and levels of CD16+ or CD56+ CD3+ cells can provide insights into the state of the immune system, especially in contexts such as autoimmune diseases, cancer immunology, and infectious diseases.
The biomarker CD3+/CD4-/CD8- identifies a unique subset of T lymphocytes that express the CD3 surface protein but lack both CD4 and CD8 co-receptors. These cells are often referred to as double-negative T cells (DN T cells) due to their absence of CD4 and CD8 expression. DN T cells represent a small fraction of the total T cell population in peripheral blood, typically accounting for less than 5% of T cells. Despite their rarity, these cells play important roles in immune regulation and have been implicated in various autoimmune diseases, transplant rejection, and cancer immunology. DN T cells can exhibit both immunosuppressive and pro-inflammatory functions, depending on the context. They are capable of producing cytokines and can have cytotoxic activity. The CD3+/CD4-/CD8- phenotype is typically assessed using flow cytometry, which allows for precise identification and quantification of this cell population. Alterations in the frequency or function of DN T cells may serve as indicators of immune dysregulation or specific disease states.f
The biomarker CD3+/CD4-/CD8- identifies a unique subset of T lymphocytes that express the CD3 surface protein but lack both CD4 and CD8 co-receptors. These cells are often referred to as double-negative T cells (DN T cells) due to their absence of CD4 and CD8 expression. DN T cells represent a small fraction of the total T cell population in peripheral blood, typically accounting for less than 5% of T cells. Despite their rarity, these cells play important roles in immune regulation and have been implicated in various autoimmune diseases, transplant rejection, and cancer immunology. DN T cells can exhibit both immunosuppressive and pro-inflammatory functions, depending on the context. They are capable of producing cytokines and can have cytotoxic activity. The CD3+/CD4-/CD8- phenotype is typically assessed using flow cytometry, which allows for precise identification and quantification of this cell population. Alterations in the frequency or function of DN T cells may serve as indicators of immune dysregulation or specific disease states.f